Literature DB >> 27993377

Recurrence Pattern of Pathologic Stage I Lung Adenocarcinoma With Visceral Pleural Invasion.

Dhihintia Jiwangga1, Sukki Cho2, Kwhanmien Kim3, Sanghoon Jheon3.   

Abstract

BACKGROUND: Visceral pleural invasion (VPI) is well known to be a poor prognostic factor in lung adenocarcinoma. There were few studies reporting postoperative recurrence pattern in lung adenocarcinoma with VPI. This study was to evaluate the clinical effect of VPI on recurrence pattern in pathologic stage I lung adenocarcinoma after curative resection.
METHODS: Among 574 patients with pathologic stage I lung adenocarcinoma after complete resection between 2003 and 2012, the clinicopathologic characteristics of 89 patients (16%) who had recurrence were retrospectively reviewed. The pathologic findings, postrecurrence survival, and patterns of recurrence were compared between patients with VPI and without VPI.
RESULTS: Median follow-up duration was 53.6 months. The VPI was found in 43 patients (group I) and not found in 46 patients (group II). Both total tumor size and invasive size were larger in group I (3.2 versus 2.7 cm and 2.5 versus 2.1 cm; p < 0.05). The median duration of overall survival was 58 months in group I and 76 months in group II. As patterns of recurrence, pleural seeding was found in 25 patients, and the percentage of pleural seeding was significantly higher in group I than group II (44.2% versus 13.0%; p = 0.001). In group I, bilateral lung metastasis was significantly common (39.5% versus 13.0%; p = 0.004), and increasing percentage of pleural seeding was observed as the invasive tumor size grows.
CONCLUSIONS: The presence of VPI was a significant predictable factor for pleural seeding and bilateral lung metastasis as patterns of recurrence after complete resection in pathologic stage I lung adenocarcinoma.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27993377     DOI: 10.1016/j.athoracsur.2016.09.052

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer.

Authors:  Su Yeon Ahn; Soon Ho Yoon; Bo Ram Yang; Young Tae Kim; Chang Min Park; Jin Mo Goo
Journal:  Eur Radiol       Date:  2018-06-15       Impact factor: 5.315

2.  Visceral Pleural Invasion in Pulmonary Adenocarcinoma: Differences in CT Patterns between Solid and Subsolid Cancers.

Authors:  Benedikt H Heidinger; Ursula Schwarz-Nemec; Kevin R Anderson; Constance de Margerie-Mellon; Antonio C Monteiro Filho; Yigu Chen; Marius E Mayerhoefer; Paul A VanderLaan; Alexander A Bankier
Journal:  Radiol Cardiothorac Imaging       Date:  2019-08-29

3.  The prognosis of stage I non-small cell lung cancer with visceral pleural invasion and whole pleural adhesion after video-assisted thoracoscopic lobectomy: A single center retrospective study.

Authors:  Youngkyu Moon; Si Young Choi; Mi Hyoung Moon
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

4.  Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.

Authors:  Chien-Sheng Huang; Hung-Che Chien; Chun-Ku Chen; Yi-Chen Yeh; Po-Kuei Hsu; Hui-Shan Chen; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang; Chun-Che Shih
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

5.  Prognostic Factors in Stage IIB Non-Small Cell Lung Cancer according to the 8th Edition of TNM Staging System.

Authors:  Jin Won Shin; Deog Gon Cho; Si Young Choi; Jae Kil Park; Kyo Young Lee; Youngkyu Moon
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2019-06-05

6.  Rethinking the Selection of Pathological T-Classification for Non-Small-Cell Lung Cancer in Varying Degrees of Visceral Pleural Invasion: A SEER-Based Study.

Authors:  Pu Fang; Jiayi Cheng; Youjin Lu; Lin Fu
Journal:  Front Surg       Date:  2022-05-19

7.  Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.

Authors:  Masaki Hashimoto; Fumihiro Tanaka; Kazue Yoneda; Teruhisa Takuwa; Seiji Matsumoto; Yoshitomo Okumura; Nobuyuki Kondo; Tohru Tsujimura; Takashi Nakano; Seiki Hasegawa
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

8.  Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.

Authors:  Yue Yu; Renhong Huang; Pei Wang; Suyu Wang; Xinyu Ling; Peng Zhang; Jingwen Yu; Jun Wang; Jian Xiao; Zhinong Wang
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

9.  The prognostic analysis of lung cancer patients with occult malignant pleural disease at thoracotomy.

Authors:  Shaolei Li; Xin Yang; Shanyuan Zhang; Miao Huang; Yuanyuan Ma; Yue Yang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.